Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|February 6, 2004
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin IIUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Nuclear Medicine and Biology|July 16, 2014
Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosisIrina Velikyan, Ulrika Rosenström, Sergio Estrada, et al.
Contrast Media & Molecular Imaging|November 4, 2017
High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26Bogdan Mitran, Helge Thisgaard, Ulrika Rosenström, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapyIrina Velikyan, Thomas N Bulenga, Ramkumar Selvaraju, et al.
Scientific Reports|November 21, 2019
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26Bogdan Mitran, Helge Thisgaard, Sara Rinne, et al.
Scientific Reports|January 17, 2018
Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PETAzita Monazzam, Joey Lau, Irina Velikyan, et al.
Bioorganic & Medicinal Chemistry|February 12, 2013
Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic--targeting Mycobacterium tuberculosis ribonucleotide reductaseJohanna Nurbo, Daniel J Ericsson, Ulrika Rosenström, et al.
International Journal of Molecular Sciences|December 23, 2023
Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ayman Abouzayed, et al.
Pageof 4